Lupin gains on launching Fluoxetine Tablets

11 Apr 2019 Evaluate

Lupin is currently trading at Rs. 806.10, up by 2.15 points or 0.27% from its previous closing of Rs. 803.95 on the BSE.

The scrip opened at Rs. 805.05 and has touched a high and low of Rs. 812.00 and Rs. 803.25 respectively. So far 24871 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 986.00 on 10-Sep-2018 and a 52 week low of Rs. 720.40 on 28-Mar-2019.

Last one week high and low of the scrip stood at Rs. 817.25 and Rs. 782.10 respectively. The current market cap of the company is Rs. 36527.55 crore

The promoters holding in the company stood at 46.98%, while Institutions and Non-Institutions held 38.84% and 14.18% respectively.

Lupin has launched Fluoxetine Tablets USP, 60mg, having received an approval from the United States Food and Drug Administration (FDA) earlier. Fluoxetine Tablets USP, 60mg, is the generic version of Alvogen Group Holdings 3 LLC’s Fluoxetine Tablets, 60mg.

It is indicated in the treatment of Major Depressive Disorder (MDD), Obsessive Compulsive Disorder (OCD), Bulimia Nervosa and panic disorder, with or without agoraphobia. Fluoxetine Tablets, 60mg, had annual sales of approximately $41 million in the US (IQVIA MAT February 2019).

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2116.15 26.50 (1.27%)
17-Dec-2025 11:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.30
Dr. Reddys Lab 1276.00
Cipla 1493.60
Zydus Lifesciences 917.00
Lupin 2116.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×